Pharma news

grey_gym_sock

actually, i'm quite pleased with the AZN board's attitude. (i've been holding AZN shares for a few years.)

i'm sure this is partly some kind of emotional reaction (on my part) to take-over bids. but there is also some logic to it: pharma seems to be a promising sector to be invested in, and it would be a pity to see the main options for UK companies to invest in reduced from 2 to 1 (GSK).

[Deleted User]

yes gadgetmind, risk and reward was one of the first things I learnt, that and support and resistance. Some shares are just not worth having because the risk far outweighs the reward

The best way to work out risk v reward is to find the support line and the potential target (easy if a previous resistance line but not easy if an unusual situation) I do try not to get into shares with too much risk ie 10% potential loss

I did happen to sell all the other sipp shares today. I have made a good profit overall and manage my husbands sipp, so have a `duty` to minimise risk as he has retired. Doh, I have to get my act together now and make a whole load of limit buys ie getting more shares for the same money. Once the limits are in then I can get back to gardening, knitting and baking cakes

I will get back into pharma but as part of asset spread, ie eggs everywhere in lots of sectors

planteria

gadgetmind wrote: »

I'd definitely buy back in if they hit my original buying price of £27 ...

...i don't think, and certainly hope, that that is likely with AstraZeneca in it's current guise.

planteria

innovate wrote: »

that's pretty much still on the cards.

is it? AstraZeneca are saying that they "believe" that Pfizer's "final" offer was indeed a final offer, but i don't entirely believe them;).. at the same time, the price sitting where it is now, 4289.75p, seems to suggest that 'the market' thinks that either Pfizer won't come back again, or that if they do, they will not be successful.

there's a big space between the closing price today and the amount that Pfizer are/were prepared to pay. how can we explain that?

gadgetmind

planteria wrote: »

...i don't think, and certainly hope, that that is likely with AstraZeneca in it's current guise.

My tongue was in my cheek, but never say never!

[Deleted User]

planteria wrote: »

is it? AstraZeneca are saying that they "believe" that Pfizer's "final" offer was indeed a final offer, but i don't entirely believe them;).. at the same time, the price sitting where it is now, 4289.75p, seems to suggest that 'the market' thinks that either Pfizer won't come back again, or that if they do, they will not be successful.

there's a big space between the closing price today and the amount that Pfizer are/were prepared to pay. how can we explain that?

sheep are still about, full of hope plus short term shorters will be closing their `bets` and the shorters include the automated hedge fund deals

planteria

"The U.S. group said its new offer was final and could not be increased. It said it would not make a hostile offer directly to AstraZeneca shareholders and would only proceed with an offer with the recommendation of the AstraZeneca board."

http://www.iii.co.uk/news-opinion/reuters/news/166641

planteria

Schroders, Axa and Jupiter are all openly criticising the AZ board for not talking with Pfizer:

http://www.iii.co.uk/articles/167260/astrazeneca-shareholder-bemoans-pfizer-rejection

planteria

Viewpoint: Neil Woodford:

http://www.iii.co.uk/articles/167526/viewpoint-deal-or-no-deal-astrazeneca

planteria

AXA have their say:

http://www.bbc.co.uk/news/business-27506556

AZ edged up yesterday, but are part way down again this morning.